Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen Marie Walker currently holds 22,636 shares of Kyverna Therapeutics, Inc. (KYTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Marie Walker has been a net seller of KYTX stock. They have purchased $0 and sold $292.8K worth of shares.
Karen Marie Walker's most recent insider trade was on Dec 15, 2025, when they sold 23,998 shares at $12.20 per share.
Karen Marie Walker serves as Executive at Kyverna Therapeutics, Inc. (KYTX). They have executed 4 insider transactions totaling $292.8K over their tenure at the company.
Karen Marie Walker holds the position of Executive at Kyverna Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Karen Marie Walker has shown a selling trading pattern, with $0 in total purchases and $292.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen Marie Walker was on Dec 15, 2025, when they sold $292.8K worth of KYTX shares. This transaction involved 23,998 shares at $12.20 per share.
Karen Marie Walker currently owns 22,636 shares of Kyverna Therapeutics, Inc. (KYTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen Marie Walker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen Marie Walker has 4 Form 4 filings on record as an insider at Kyverna Therapeutics, Inc..
Set alerts for Karen Marie Walker and 40,000+ other insiders.